Related Experiment Videos
[Mutual effects of drugs in the gastrointestinal tract]
Medizinische Monatsschrift Fur Pharmazeuten
|October 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Analytical approaches for MCPD esters and glycidyl esters in food and biological samples: a review and future perspectives.
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment·2012
Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease.
Dementia and geriatric cognitive disorders·2012
Mapping of phosphorylation-dependent anti-tau monoclonal antibodies in immunoblots using human tau-constructs synthesized by native chemical ligation.
Biochemical and biophysical research communications·2007
Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response.
British journal of clinical pharmacology·2007
The applications of biomarkers in early clinical drug development to improve decision-making processes.
Ernst Schering Research Foundation workshop·2006
Zika virus infections.
Medizinische Monatsschrift fur Pharmazeuten·2018
Pitolisant for the treatment of narcolepsy with or without cataplexy.
Medizinische Monatsschrift fur Pharmazeuten·2018
Curses or blessings? Opioids in non cancer chronic pain.
Medizinische Monatsschrift fur Pharmazeuten·2018
The cancer patient’s soul.
Medizinische Monatsschrift fur Pharmazeuten·2018
The psoriasis patient – an exemplification of interdisciplinarity.
Medizinische Monatsschrift fur Pharmazeuten·2018
Management of psoriasis.
Medizinische Monatsschrift fur Pharmazeuten·2018
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.
Immunity, inflammation and disease·2026